After selection of these extreme groups, the relationship of p-ATM with poor response-to-treatment was even stronger compared to Model I. These data indicate that pre-treatment ATM activity levels, but not phosphorylation status of 53BP1, is relevant for the response to (chemo)radiation in patients with cervical cancer. This evidence concerns the gene TP53BP1 and cervical carcinoma.